Children's Hospital of Wisconsin
For Physicians & Health ProfessionalsChildren's Hospital and Health System
Search
Health InformationPrograms & ClinicsFind a DoctorGiving & VolunteeringResearchAdvocacy & CommunitySafety & QualityContact UsCareers

  Choose a Condition or Topic
 
  Programs & Clinics
 
 
  Overview of Dermatology Program
spacing image spacing image
spacing image Contact Us
 
 
  Clinic Information
 
  Our Specialists
 
E-mail this pageE-mail this page    Print this pagePrint this page    

Kasabach-Merritt phenomenon

See Also...

Request an Appointment
Family Accommodations
Billing Information
Virtual Tours
Handouts/Teaching Sheets


Related Links
Types of birthmarks
Infantile Hemangiomas
Congenital Hemangiomas
Vascular malformations
PHACES Syndrome
MLT
Sturge-Weber syndrome
Laser slide shows
The Kasabach-Merritt phenomenon, a complication of rapidly enlarging vascular lesion, is characterized by hemolytic anemia, thrombocytopenia and coagulopathy. Most cases can be seen in the first weeks of life. The vascular tumors that cause KMP are large, deep red-blue color, firm, grow rapidly, affect boys and girls equally and tend to grow for a longer period of time (two to five years). It now is clear that most patients with true Kasabach-Merritt phenomenon do not have hemangiomas of infancy, but rather other more aggressive, proliferative vascular tumors. Kaposiform hemangioendotheliomas and tufted angiomas are the tumors most often associated with this phenomenon. They can be very serious, even fatal, and require aggressive and often many different types of treatment.

Hospital locations: Milwaukee and Fox Valley.

Children's Hospital of Wisconsin in Milwaukee, serving Wisconsin, Northern Illinois and
Michigan's Upper Peninsula and beyond through nationally-recognized programs.

Report any problems or comments about this Web site to webmaster@chw.org.
Terms of Use and Privacy Policies. © 2012 Children's Hospital and Health System.